Lifemd, Inc. · NASDAQ:LFMD

Lifemd — Immudyne — Investor Presentation (May 2018)

15 slides from Lifemd's investor presentation, May 24, 2018

  1. Slide 1: Immudyne, Inc. 2018 Corporate Presentation

    IMM U DYN E, INC 2 2018 CORPORATE PRESENTATION

  2. Slide 2: Safe Harbor

    SAFE HARBOR ‘Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995, Statements may contain certain forward-lo

  3. Slide 3: Corporate Highlights

    CORPORATE HIGHLIGHTS IMMUDYNE IS A TECHNOLOGY DRIVEN ONLINE MARKETING COMPANY THAT CREATES AND GROWS INNOVATIVE BRANDS IN THE HEALTHCARE AND TECHNOLOGY SECTORS o°o 0 86 @O GROWING PROFITABLE ‘SCALABLE PROPRIETARY Transformational sales Cash flow positive with Capital efficient, global Robust portfol

  4. Slide 4: Our Business Model

    OUR BUSINESS MODEL Vertically integrated Platform Marketing Partners Conversion PRODUCT DEVELOPMENT vnRKerin TECHNOLOGY DIRECT To-COnSUMER AEMARKET + uu, create PLATFORM CEES] + Other Products > Inicense + Monetize Data + Acquire M Googe haves Biowibe| so.ccisag Medi Buying Tabla Cutbrain LQ BRANDIN

  5. Slide 5: Discipline + Execution = Scalability

    | DISCIPLINE + EXECUTION = SCALABILITY ‘Accelerating Revenue Growth* Disciplined, Low Risk Strategy tuwuoyne [8

  6. Slide 6: Product Portfolio

    PRODUCT PORTFOLIO ‘OUR PRODUCT PORTFOLIO IS COMPRISED OF PROPRIETARY ONLINE BRANDS THAT ARE HIGHLY SCALABLE AND ADDRESS LARGE UNMET MARKET NEEDS SHAPIRO MD Commercial . Wellness Commercial scarology 03 2018+ Purpurex® 08 2038" vuwuoyne | 8

  7. Slide 7: Our Brands

    © OUR BRANDS

  8. Slide 8: Shapiro MD

    SHAPIRO MD DHT BLOCKING HAIR CARE AID Developed by distinguished dermatologists Dr © Steven Shapiro, M.D,, and Dr. Michael Borenstein, M.D. PhD © 2US. Patents; 15 years of product development ‘and formulation work ‘@ Contains 3 naturally occurring DHT blocking ingredients ‘e. 25.000+ customers since

  9. Slide 9: INR Wellness

    INR WELLNESS BETA GLUCAN IMMUNE SUPPORT SUPPLEMENT Triple-action containing higt mushroom glu scan supplement ty yeast, oat and ‘@ Contains Immudyne’s proprietary ¥.1-3-1,6 Yeast Beta Glucan @ Attractive category; immune support is large ‘market with minimal OTC innevation © Product launched Q2 2018

  10. Slide 10: Scarology

    SCAROLOGY TRIPLE ACTION SCAR HEALING SOLUTION Scarology is a scar heali through a simple, three routine solution delivered p day and night Three essential ingrec work together to © achieve dramatic resi appearance and feel Clinically proven and developed by scar therapy © experts and prominent Palm

  11. Slide 11: Purpurex

    PURPUREX CLINICALLY PROVEN NUTRACEUTICAL FOR BRUISING ‘@ First and only treatment for solar purpura, a common skin condition which affects ~12%6 of individuals over the age of 50 worldwide Unique nutraceutical formulation that has been clinically shown to reduce the appearance and duration of solar

  12. Slide 12: Executive Team

    EXECUTIVE TEAM a EE 2. JUSTIN STEFAN ROBERT JUAN JOE SCHREIBER GALLUP AUSTEN PINIERD orrrouo tuuoyne | 2

  13. Slide 13: Financials

    FINANCIALS Immudyne is a technology driven online marketing company creating shareholder value through responsible, long-term growth of our core online brands. 2018 Catalysts: + Revenue growth Additional licensing deals Strengthening of executive team + Product endorsements + Uplisting to NYSE Amex

  14. Slide 14: Investment Summary

    INVESTMENT SUMMARY © Profitable & Growing. Immudyne is profitable and anticipates significant sales growth in FY2018, @ Incredible Products. Our portfolio of products address large unmet needs and are backed by real science ‘and accomplished medical opinion leaders. @ Large Addressable Market. Al of

  15. Slide 15: Contact Us

    | CONTACT US JUSTIN SCHREIBER ROBERT KALKSTEIN PRESIDENT & CEO CFO JUSTIN@JLSVENTURES.COM ROBERT@IMMUDYNE.COM 717.381.7492 866.351.5907 tuwuoyne [15

Immudyne — Investor Presentation (May 2018) on 6ix